stockrowResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) Total debt
ResMed Inc.'s total debt at the end of fiscal 2026 was $399.4M, down 39.3% from $658.4M in fiscal 2025. At the end of the quarter to 30 September 2026 it was $249.6M. Over the past ten years it has ranged from $270.0M (fiscal 2018) to $1.4B (fiscal 2023); the current reading is higher than 25% of that period. ResMed Inc. ranks 18th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $399.4M | (39.33%) |
| FY2025 | $658.4M | (5.58%) |
| FY2024 | $697.3M | (51.28%) |
| FY2023 | $1.4B | 87.01% |
| FY2022 | $765.3M | 18.96% |
| FY2021 | $643.4M | (44.74%) |
| FY2020 | $1.2B | (7.52%) |
| FY2019 | $1.3B | 366.27% |
| FY2018 | $270.0M | (74.97%) |
| FY2017 | $1.1B | 23.51% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $249.6M | (37.50%) |
| Jun 2026 | $399.4M | (1.18%) |
| Mar 2026 | $404.2M | 0.06% |
| Dec 2025 | $403.9M | (1.16%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| BDX Becton, Dickinson and Company compare | $13.5B |
| MDLN Medline Inc. compare | $12.6B |
| BAX Baxter International Inc. compare | $8.6B |
| ALC Alcon compare | $4.7B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| SOLV Solventum Corporation compare | $507.0M |
| RMD ResMed Inc. | $249.6M |
| WST West Pharmaceutical Services, Inc. compare | $202.9M |
| ALGN Align Technology, Inc. compare | $127.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement